Corindus Vascular Robotics and Acist Medical Systems have come together to provide Fairview Southdale Hospital (Edina, USA) with three leading-edge technologies that are designed to improve workflow. The technologies are the CorPath system, which is the first FDA-cleared robotic-assisted system for percutaneous coronary intervention (PCI); ACIST RXi, which aims to provide the reassurance of accurate and reliable fractional flow reserve (FFR) measurements and the advantages of rapid exchange technology; and ACIST CVi, the purpose of which is to simplify contrast injection for procedures while enhancing safety, efficiency, control and image quality.
Gregory Helmer (co-Director of Medical Research, Fairview Southdale Hospital, USA), says: “I am excited to work with both companies to bring innovative solutions to the cath lab that enhance patient care. Rapid FFR and Robotic PCI are significant contributions to PCI procedures and may improve safety, lesion assessment, and bring further precision to our interventional procedures.”
“Both Corindus and ACIST share the strong vision of how physicians and their teams should operate in the cath lab. This collaboration is the first step towards realizing this vision by providing innovative solutions to optimize workflow, improve safety, and eventually enhance patient care,” comments Mark Toland, chief executive officer at Corindus Vascular Robotics.
